小児心疾患に対する画期的な胎児治療法を開発(UH Cardiac Researcher Develops Breakthrough Advancement in Battling Pediatric Heart Disease)

ad

2026-01-20 ヒューストン大学(UH)

米国のヒューストン大学の薬理学研究者Mingfu Wu教授は、小児の重篤な心疾患である左室緻密化障害(LVNC、いわゆるスポンジ心)の新たな原因と、胎児期に介入可能な部分的治療法を突き止めた。研究によると、心臓表面の外膜細胞に存在するNumbファミリータンパク質(NFPs)の機能喪失が、線維芽細胞の形成不全とFGF(線維芽細胞増殖因子)シグナルの破綻を引き起こし、心筋発達に不可欠な細胞間コミュニケーションが失われる。その結果、左心室が十分に緻密化せず、拍出機能が低下したスポンジ状心臓が形成されることが示された。さらに、妊娠中に母体へFGFを投与すると、胎児の心臓発達異常が部分的に改善されることも確認された。本成果は学術誌Circulation Heart Failureに掲載され、先天性心疾患だけでなく、将来の成人心筋症治療にもつながる可能性を示している。

小児心疾患に対する画期的な胎児治療法を開発(UH Cardiac Researcher Develops Breakthrough Advancement in Battling Pediatric Heart Disease)
A new therapeutic approach, performed in utero, may prevent babies from being born with a spongy heart — a life-threatening disease which often causes the dire need for a heart transplant.

<関連情報>

NFP-FGFシグナル伝達を介した心外膜由来細胞の小柱への浸潤が心室緻密化を制御する Invasion of Epicardial-Derived Cells to the Trabeculae Mediated by NFPs-Fgf Signaling Regulates Ventricular Compaction

Anika Nusrat, PhD, Luqi Zhao, MD, Lianjie Miao, PhD, Shiyanth Thevasagayampillai, BS, Xi Lu, PhD, Aaranyah Kandasamy, BS, Md Areeful Haque, PhD, Preethi H. Gunaratne, PhD, Sylvia M. Evans, PhD, and Mingfu Wu, PhD
Circulation: Heart Failure  Published 1 January 2026
DOI:https://doi.org/10.1161/CIRCHEARTFAILURE.125.013210

Abstract

BACKGROUND:

Left ventricular noncompaction cardiomyopathy (LVNC; OMIM No. 604169) is anatomically characterized by excess trabeculation and deep intertrabecular recesses. It is the third most prevalent pediatric cardiomyopathy. Despite its clinical significance, the pathogenesis of LVNC remains uncertain.

METHODS:

We examined Numb expression in epicardial cells (EpiCs) and epicardial-derived cells (EPDCs) using a mCherry::Numb knock-in mouse line; used Tbx18Cre/+ and inducible WT1CreERT2/+ to generate epicardium-specific Numb and Numblike double knockouts (epicardial Nb;Nl double knockout [EDKO]) and inducible EpiC-specific Nb;Nl knockout, respectively; monitored EpiCs/EPDCs invasion into the myocardium by lineage tracing; assessed LVNC defects via the ratio of noncompact to compact zone thickness/area; utilized single-nuclei mRNA sequencing and biochemical tools to determine the disrupted molecular mechanisms of EDKOs; and used pharmacological approaches to rescue defects in EDKOs. Cardiac structural and functional changes in adult stages were examined using echocardiography and histochemistry. Sample sizes ranged from 3 to 9 hearts across experiments.

RESULTS:

Numb is enriched in EpiCs and EPDCs. In EDKO hearts, EPDCs displayed abnormal differentiation, and their migration was arrested at the outer compact zone, resulting in the absence of EPDCs in the inner compact zone and trabeculae. The EDKO hearts displayed LVNC, and inducible EpiC-specific Nb;Nl knockouts (induced at embryonic day 10.5) recapitulated the defects. Single-nuclei mRNA sequencing revealed the upregulation of Fgfr1 (fibroblast growth factor receptor 1) in epicardium and the downregulation of Fgf (fibroblast growth factor) ligands in cardiomyocytes in EDKOs. Exogenous Fgf2 supplementation to pregnant females partially rescued epithelial-mesenchymal transition and compaction defects in EDKO hearts. Female EDKOs survived to adulthood and maintained LVNC.

CONCLUSIONS:

Ablation of NFPs (numb family proteins) in EpiCs disrupted the invasion and differentiation of EPDCs and the communication between cardiomyocytes and other cells, and caused LVNC. The epithelial-mesenchymal transition and compaction defects can be partially rescued by exogenous Fgf2 supplementation. Our findings highlight an essential role for the epicardial NFPs–Fgf/Fgfr axis in regulating ventricular compaction.

医療・健康
ad
ad
Follow
ad
タイトルとURLをコピーしました